Cadence Minerals #KDNC – Bacanora Lithium #BCN – Sonora Lithium Project, Lithium Market & Covid-19 Update.

Cadence Minerals (AIM/NEX: KDNC; OTC: KDNCY) notes the update published today by Bacanora Lithium (AIM:BCN) (“Bacanora”), both on the Lithium market, and on its activities at the Sonora Lithium Project in Mexico (‘Sonora’ or the ‘Project’) in light of the ongoing Covid-19 pandemic. Cadence Minerals – Holdings in Mexalit and Megalit: Bacanora is a lithium […]
Alan Green discusses Blencowe Resources #BRES, Kibo Energy #KIBO & Eddie Stobart #ESL on UK Investor Magazine podcast

Alan Green discusses Blencowe Resources #BRES, Kibo Energy #KIBO & Eddie Stobart #ESL with Jonathan Roy on the UK Investor Magazine podcast. Link on the image to go to. the podcast.
Blencowe Resources #BRES – New High-Grade Graphite Zone Identified at Orom-Cross Project

The Company is pleased to provide a further update to its ongoing comprehensive JORC Resource diamond drilling program at the Orom-Cross Graphite Project in Northern Uganda. Highlights Following a review and remodelling of geophysical survey program data acquired earlier this year, as well as historical pitting and drill results, a highly prospective High-Grade Zone has […]
Cadence Minerals #KDNC – Macarthur Minerals (TSX-V: MMS) Joint Venture Partner Fe Limited announces sale of Evanston royalty.

Cadence Minerals (AIM/NEX: KDNC; OTC: KDNCY) is pleased to note that Macarthur Minerals (TSX-V: MMS) (“Macarthur”) Joint Venture Partner, Fe Limited (“FEL”) has announced approval by its Shareholders for the sale of its Evanston royalty interest over a portion of the wider Koolyanobbing iron ore mine in the Southern Yilgarn region of Western Australia. TRR […]
Graphite miner Blencowe set to shine in 2020 – UK Investor Magazine

The latest resource company to list on LSE – Blencowe Resources (LON: BRES) – has enjoyed a strong few weeks of trading since relisting on April 28th, moving up nearly 50% from 6p towards 9p in a weak market where many of its peers are heading in the opposite direction. What makes Blencowe and its […]
Kibo Energy #KIBO – Mast Energy Developments & Bordersley Update – RNS

Kibo Energy PLC, the multi-asset, Africa focused, energy company, is pleased to provide an update on its subsidiaries, Bordersley Power Ltd (‘Bordersley’) and Mast Energy Developments Ltd (‘MED’). The Bordersley 5 MW gas-fuelled power generation plant in the UK is currently being developed for Kibo by the Company’s 60% owned subsidiary, manager and operator of Bordersley, MED. Overview * […]
Financial Times – Europe eclipses China in electric vehicle investment

by Joe Miller EU carmakers help close the gap as they race to comply with strict CO2 emissions targets Europe has outpaced China in attracting investment for electric vehicles and battery development, securing a record €60bn last year largely as a result of Volkswagen’s push into emissions-free cars. The figure, compiled by Brussels-based non-profit Transport […]
Open Orphan #ORPH – Results of Fundraising

Open Orphan plc (ORPH), a rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is the world leader in the testing of vaccines and antivirals using human challenge study models, announces that, further to its announcement at 7.00 a.m. today (the “Fundraising Announcement”), it has successfully completed the oversubscribed […]
LocoSoco Group Plc #LOCO – New Partnership Agreements & Board Advisory Appointments

LocoSoco Group Plc, the company that builds technology to profit from creating sustainable communities and is listed on the Direct Market segment of the Vienna MTF, is pleased to provide details of new partnership agreements with Purview and LickList, distributor exclusivity for a new hand sanitiser product, additional sites with Co-Op and James’s Retail and […]
Tiziana Life Sciences #TILS – Demerger of StemPrintER Genomics-Based Personalized Medicine business as a separate listed company

New York and London, May 22, 2020 – Tiziana Life Sciences plc (NASDAQ: TLSA, AIM: TILS), a clinical stage biotechnology company developing targeted drugs for cancer, inflammatory diseases and COVID-19, today announces that it intends to demerge its StemPrintER and SPARE (together “StemPrintER”) genomics-based personalized medicine businesses into a separate company and effect a capital […]